Literature DB >> 2496006

The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.

A B Shyu1, M E Greenberg, J G Belasco.   

Abstract

Rapid degradation of c-fos proto-oncogene mRNA is crucial for transient c-fos gene expression. Experiments were performed to investigate the cellular mechanisms responsible for the extremely short half-life of human c-fos mRNA in growth-factor-stimulated fibroblasts. These experiments demonstrate the existence of two distinct cellular pathways for rapid c-fos mRNA degradation. Each of these pathways recognizes a different, functionally independent instability determinant within the c-fos transcript. One instability determinant, which is located within the c-fos 3'-untranslated region, is a 75-nucleotide AU-rich segment. Insertion of this element into beta-globin mRNA markedly reduces the half-life of that normally long-lived message. Nevertheless, specific deletion of the AU-rich element from c-fos mRNA has little effect on the transcript's cytoplasmic half-life due to the presence of the other c-fos instability determinant, which is located in the protein-coding segment of the c-fos message. Examination of mRNA decay in cells treated with transcription inhibitors indicates that one c-fos mRNA degradation pathway is dependent on RNA synthesis, whereas the other is not.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496006     DOI: 10.1101/gad.3.1.60

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  199 in total

1.  Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique.

Authors:  S A Brooks; W F Rigby
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.

Authors:  W Wang; M C Caldwell; S Lin; H Furneaux; M Gorospe
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

3.  HuR regulates p21 mRNA stabilization by UV light.

Authors:  W Wang; H Furneaux; H Cheng; M C Caldwell; D Hutter; Y Liu; N Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  The identification of an endonuclease that cleaves within an HuR binding site in mRNA.

Authors:  Z Zhao; F C Chang; H M Furneaux
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

5.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover.

Authors:  N Xu; C Y Chen; A B Shyu
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Comparative analysis of the plant mRNA-destabilizing element, DST, in mammalian and tobacco cells.

Authors:  M Feldbrügge; P Arizti; M L Sullivan; P D Zamore; J G Belasco; P J Green
Journal:  Plant Mol Biol       Date:  2002-05       Impact factor: 4.076

8.  Role of mRNA stability and translation in the expression of cytochrome c oxidase during mouse myoblast differentiation: instability of the mRNA for the liver isoform of subunit VIa.

Authors:  E L Thames; D A Newton; S A Black; L H Bowman
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 9.  Genome-wide technology for determining RNA stability in mammalian cells: historical perspective and recent advantages based on modified nucleotide labeling.

Authors:  Hidenori Tani; Nobuyoshi Akimitsu
Journal:  RNA Biol       Date:  2012-10-01       Impact factor: 4.652

10.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.